Chemical Stability of Telavancin in Elastomeric Pumps()

por Sand, Patrick, Aladeen, Traci, Kirkegaard, Paul, LaChance, Dennis, Slover, Christine
Publicado 2015

2753. Real-World Use of Cefiderocol Treating Non-COVID Patients with Confirmed Gram-Negative Infections in US Hospitals During January 2020-June 2022

por Cai, Bin, Zhou, Yun, Slover, Christine M, Copeland, Jennifer D, Nguyen, Sean T
Publicado 2023

Cefiderocol For Injection: Compatibility Testing Using the MINI-BAG Plus Container System and the VIAL-MATE Adaptor

por Rathod, Dhaval, Chen, Zhengming, Slover, Christine M., Kung, Frank, Morita, Junichi, Nguyen, Sean T.
Publicado 2023

2750. Pseudomonas aeruginosa infections treated with cefiderocol: associations of site of infection and time to first dose with outcomes in PROVE (Retrospective Cefiderocol Chart R...

por Marcella, Stephen, Cai, Bin, Friedman, Bruce, Verardi, Stefano, Gozalo, Laurence, Slover, Christine M
Publicado 2023

2751. Cefiderocol Use in Treating Patients with Confirmed Stenotrophomonas maltophilia Infections in US Hospitals During January 2020 - June 2022

por Cai, Bin, Nguyen, Sean T, Copeland, Jennifer D, Song, Hyun Jin, Slover, Christine M
Publicado 2023

Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance

por Longshaw, Christopher M, Santerre Henriksen, Anne, Slover, Christine, Yamano, Yoshinori, Karas, J Andreas
Publicado 2022

Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive

por Safir, M. Courtney, Bhavnani, Sujata M., Slover, Christine M., Ambrose, Paul G., Rubino, Christopher M.
Publicado 2020

Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program

por Satlin, Michael J., Simner, Patricia J., Slover, Christine M., Yamano, Yoshinori, Nagata, Tsutae D., Portsmouth, Simon
Publicado 2023

1715. In Vitro Antibacterial Activity of Cefiderocol against Difficult-to-treat Resistant (DTR) Gram-negative Pathogens in United States from SENTRY Antimicrobial Surveillance Prog...

por Yamano, Yoshinori, Takemura, Miki, Shortridge, Dee, Slover, Christine M, Longshaw, Christopher M, Echols, Roger, Echols, Roger, Echols, Roger
Publicado 2022

603. Determining Effect of Media and Disk Source on Reproducibility and Relationship between Broth Microdilution and Disk Diffusion Testing of Cefiderocol

por Takemura, Miki, Saiki, Mizue, Yamashiro, Hidenori, Anan, Naomi, DeJonge, Boudewijn L, Slover, Christine M, Longshaw, Christopher M, Henriksen, Anne, Yamano, Yoshinori
Publicado 2023

1734. Susceptibility of Cefiderocol between US Census Regions against Gram-Negative Organisms collected from the SENTRY Surveillance Program: 2020-2021

por Kung, Frank H, Nguyen, Sean, Slover, Christine M, Shortridge, Dee, Streit, Jennifer M, Echols, Roger, Echols, Roger, Echols, Roger, Takemura, Miki, Yamano, Yoshinori
Publicado 2022